| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bridgebio Pharma, Inc. (BBIO) has 13 insiders with recent SEC Form 4 filings, including 7 buys and 18 sells. BBIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 18.56M | $1.28B | - | |
| 10% | 14.59M | $1.01B | - | |
| CEO | 4.40M | $303.14M | - | |
| Dir | 916.7K | $63.18M | - | |
| Dir | 766.6K | $52.83M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2020 | Stephenson Brian C | See Remarks | Sell | 10,800 | $32.93 | $355,683.31 | -0.5% | |
| Dec 30, 2019 | McCormick Frank61 | Chairman Of Oncology | Sell | 100,000 | $37.55 | $3,755,379.27 | -0.8% | |
| Jul 3, 2019 | Bridgebio Pharma, Inc. | 10% Owner | Buy | 882,353 | $29.90 | $26,382,795.88 | +3.7% | |
| Jul 1, 2019 | Stephenson Brian C | See Remark | Buy | 55,500 | $17.00 | $943,500.00 | +17.7% | |
| Jul 1, 2019 | Sinha Uma | Chief Scientific Officer | Buy | 14,000 | $17.00 | $238,000.00 | New | |
| Jul 1, 2019 | Henderson Michael Thomas58 | See Remarks | Buy | 7,000 | $17.00 | $119,000.00 | +4.0% | |
| Jun 27, 2019 | Viking Global Performance LLC | 10% Owner | Buy | 4,705,900 | $17.00 | $80,000,300.00 | +21.5% | |
| Jun 27, 2019 | Viking Global Investors LP66 | 10% Owner | Buy | 4,705,900 | $17.00 | $80,000,300.00 | +21.5% | |
| May 24, 2019 | Bridgebio Pharma, Inc. | 10% Owner | Buy | 1,103,848 | $25.93 | $28,622,778.64 | +4.9% | |
| Dec 10, 2018 | Bridgebio Pharma LLC | 10% Owner | Sell | 40,653 | $13.33 | $542,063.25 | - |